Bupropion HCl SR 150mg Tablets from Canada
Sustained-release bupropion hydrochloride 150mg tablets for smoking cessation and depression via CNS norepinephrine/dopamine reuptake inhibition. HTS 3004.90.92.49 applies to these other CNS therapeutic medicaments in measured retail doses, distinct from nicotine cessation products in 2404.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Document non-nicotine basis to distinguish from heading 2404 exclusions
• Test for controlled substance scheduling; bupropion analogs may trigger DEA review
• Use temperature-controlled shipping for stability in SR formulations